| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.38B | +16.6% |
| Cost of Revenue | $8.98B | +22.2% |
| Gross Profit | $7.40B | +10.5% |
| R&D Expense | $991.0M | +20.9% |
| SG&A Expense | $2.18B | +20.7% |
| Operating Income | $36.0M | -95.9% |
| Interest Expense | $576.0M | +20.0% |
| Pre-tax Income | -$121.0M | -856.3% |
| Income Tax | $286.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.83B | +19.4% |
| Accounts Receivable | $190.0M | +93.9% |
| Current Assets | $4.80B | +10.4% |
| Total Assets | $29.28B | +19.5% |
| Current Liabilities | $5.04B | +9.9% |
| Long-term Debt | $12.27B | +82.1% |
| Total Liabilities | $19.58B | +47.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.18B | -26.1% |
| Capital Expenditures | $105.0M | -27.1% |
| Investing Cash Flow | -$3.48B | -329.2% |
| Financing Cash Flow | $2.43B | +617.7% |
| Free Cash Flow | $1.08B | -26.0% |
| +295.9% |
| Net Income | -$407.0M | -351.2% |
| EPS (Basic) | -$1.75 | -829.2% |
| EPS (Diluted) | -$1.75 | -829.2% |
| Stockholders' Equity |
| $9.04B |
| -2.7% |